Status:
COMPLETED
Lymphatic Mapping After Previous Breast Surgery
Lead Sponsor:
Catharina Ziekenhuis Eindhoven
Conditions:
Breast Cancer
Sentinel Node
Eligibility:
FEMALE
18+ years
Brief Summary
Rationale: Like in primary breast cancer, prognosis in recurrent breast cancer is correlated with regional lymph node status. Therefore, axillary staging may be warranted in patients with recurrent di...
Eligibility Criteria
Inclusion
- treatment with BCT with SNB and/or ALND for primary breast cancer
- previous primary breast cancer located in the upper-outer quadrant of one breast
- Primary breast cancer treatment at least 3 years before the analysis, with or without adjuvant chemo- or hormonal therapy.
Exclusion
- breast surgery for other reasons than breast cancer
- recurrent breast cancer
- former allergic reaction to 99mTc-colloidal albumin.
Key Trial Info
Start Date :
Trial Type :
OBSERVATIONAL
End Date :
Estimated Enrollment :
Patients enrolled
Trial Details
Trial ID
NCT01164748
Last Update
July 19 2010
Active Locations (1)
Enter a location and click search to find clinical trials sorted by distance.
1
Catharina Hospital
Eindhoven, Netherlands, 5623 EJ